These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 34326699)
1. Downregulation of m Wang J; Tan L; Jia B; Yu X; Yao R; OUYang N; Yu X; Cao X; Tong J; Chen T; Chen R; Li J Int J Biol Sci; 2021; 17(10):2633-2651. PubMed ID: 34326699 [TBL] [Abstract][Full Text] [Related]
2. lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942/TNS1 axis and is positively regulated by the m Wang J; Tan L; Yu X; Cao X; Jia B; Chen R; Li J Mol Cancer; 2022 Dec; 21(1):229. PubMed ID: 36581942 [TBL] [Abstract][Full Text] [Related]
3. YTHDC2 Retards Cell Proliferation and Triggers Apoptosis in Papillary Thyroid Cancer by Regulating CYLD-Mediated Inactivation of Akt Signaling. Zhou G; Wang S Appl Biochem Biotechnol; 2024 Jan; 196(1):588-603. PubMed ID: 37162682 [TBL] [Abstract][Full Text] [Related]
4. The m6A Reader YTHDC2 Suppresses Lung Adenocarcinoma Tumorigenesis by Destabilizing MRPL12. Sun Y; Liu Y; Wang P; Chang L; Huang J Mol Biotechnol; 2024 May; 66(5):1051-1061. PubMed ID: 38129673 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of m Sun S; Han Q; Liang M; Zhang Q; Zhang J; Cao J Thorac Cancer; 2020 Nov; 11(11):3269-3279. PubMed ID: 32956555 [TBL] [Abstract][Full Text] [Related]
6. miR-130b, an onco-miRNA in bladder cancer, is directly regulated by NF-κB and sustains NF-κB activation by decreasing Cylindromatosis expression. Cui X; Kong C; Zhu Y; Zeng Y; Zhang Z; Liu X; Zhan B; Piao C; Jiang Z Oncotarget; 2016 Jul; 7(30):48547-48561. PubMed ID: 27391066 [TBL] [Abstract][Full Text] [Related]
7. Rig-G is a growth inhibitory factor of lung cancer cells that suppresses STAT3 and NF-κB. Li D; Sun J; Liu W; Wang X; Bals R; Wu J; Quan W; Yao Y; Zhang Y; Zhou H; Wu K Oncotarget; 2016 Oct; 7(40):66032-66050. PubMed ID: 27602766 [TBL] [Abstract][Full Text] [Related]
8. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD. Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR‑181b inhibits human colon cancer cell proliferation by targeting CYLD and inhibiting the NF‑κB signaling pathway. Yang X; Sun Y; Zhang Y; Han S Int J Mol Med; 2020 Nov; 46(5):1755-1764. PubMed ID: 32901872 [TBL] [Abstract][Full Text] [Related]
10. KLHL21/CYLD signaling confers aggressiveness in bladder cancer through inactivating NF-κB signaling. Yuan H; Wei S; Ren Z; Li F; Liu B; Liu R; Zhang X Int Immunopharmacol; 2023 Jan; 114():109202. PubMed ID: 36538852 [TBL] [Abstract][Full Text] [Related]
11. The m Ma L; Chen T; Zhang X; Miao Y; Tian X; Yu K; Xu X; Niu Y; Guo S; Zhang C; Qiu S; Qiao Y; Fang W; Du L; Yu Y; Wang J Redox Biol; 2021 Jan; 38():101801. PubMed ID: 33232910 [TBL] [Abstract][Full Text] [Related]
12. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression. Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326 [TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking induces aberrant N Jin M; Li G; Liu W; Wu X; Zhu J; Zhao D; Zeng Z; Xiong M; Song Y; He X; Zhang Q; Hu K Cancer Lett; 2021 Oct; 518():214-229. PubMed ID: 34298122 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of CYLD downregulation in breast cancer. Hayashi M; Jono H; Shinriki S; Nakamura T; Guo J; Sueta A; Tomiguchi M; Fujiwara S; Yamamoto-Ibusuki M; Murakami K; Yamashita S; Yamamoto Y; Li JD; Iwase H; Ando Y Breast Cancer Res Treat; 2014 Feb; 143(3):447-57. PubMed ID: 24398777 [TBL] [Abstract][Full Text] [Related]
15. A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer. Zhao Z; Miao Z; Hou Y; Zhong Y; Zhang X; Fang X Int Immunopharmacol; 2024 Sep; 139():112691. PubMed ID: 39029230 [TBL] [Abstract][Full Text] [Related]
16. CYLD downregulates Livin and synergistically improves gemcitabine chemosensitivity and decreases migratory/invasive potential in bladder cancer: the effect is autophagy-associated. Yin L; Liu S; Li C; Ding S; Bi D; Niu Z; Han L; Li W; Gao D; Liu Z; Lu J Tumour Biol; 2016 Sep; 37(9):12731-12742. PubMed ID: 27448305 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas. Wang J; Zou K; Feng X; Chen M; Li C; Tang R; Xuan Y; Luo M; Chen W; Qiu H; Qin G; Li Y; Zhang C; Xiao B; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W Mol Cancer; 2017 Oct; 16(1):158. PubMed ID: 29025423 [TBL] [Abstract][Full Text] [Related]
18. [LIM-domain binding protein 2 regulated by m Zhai D; Wang G; Li L; Jia X; Zheng G; Yin J Nan Fang Yi Ke Da Xue Xue Bao; 2021 Mar; 41(3):329-335. PubMed ID: 33849822 [TBL] [Abstract][Full Text] [Related]
19. miR-130b regulates B cell proliferation via CYLD-mediated NF-κB signaling. Wu M; Zhao J; Wu W; Hao C; Yang Y; Zhang J Exp Cell Res; 2024 Jan; 434(1):113870. PubMed ID: 38049082 [TBL] [Abstract][Full Text] [Related]
20. Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1. Pu J; Wu X; Wu Y; Shao Z; Luo C; Tang Q; Wang J; Wei H; Lu Y Aging (Albany NY); 2021 Mar; 13(8):12207-12223. PubMed ID: 33952719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]